1-aryl-3-arylmethyl-1,8-naphthyridin-4(1H)-ones
US6174895A · kind A · utility
Assignee
Inventor
Key dates
| Filing date | Aug 11, 1999 |
| Grant date | Jan 16, 2001 |
| Priority date | — |
| Expiry date | Aug 11, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of the formula ##STR1## or the pharmaceutically acceptable salt thereof, wherein R.sup.1, R.sup.2 and R.sup.3 are as defined above, useful in the treatment of respiratory, allergic, rheumatoid, body weight regulation, inflammatory and central nervous system disorders such as asthma, chronic obstructive pulmonary disease, adult respiratory diseases syndrome, toxic shock, fibrosis, pulmonary hypersensitivity, allergic rhinitis, atopic dermatitis, psoriasis, weight control, rheumatoid arthritis, cachexia, Crohn's disease, ulcerative colitis, arthritic conditions and other inflammatory diseases, depression, multi-infarct dementia and AIDS.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.